Greenlife Pharmaceuticals primary business focus is on the healthcare delivery. The company has the vision of “being a vanguard of healthy living and a choice companion to all her publics”. The company has over time introduced some pharmaceutical products of various theraphutical segments which has become brand leaders into the Nigerian markets viz: Anti-Malarials, Anti-Infectives, Anti-Inflammatory, Anti-Helminthes, Anti-Hypertensive, Laxatives, Multivitamins among others. The company products are also marketed in some other countries in the West Cost of Africa.
_x000D_
_x000D_ At present the company has over seventy Five (75) NAFDAC registered products in its stable. These include the WHO and FMHO recently approved Atemesinin based Anti-Malaria drugs of which Lonart® a brand of Artemisinin is the company’s flagship. Others are givther Injection® (Atemether) Gsunate Forte® (Artesunate) Alaxin® (Dihydroartemisinin) Gsunate Kit® (Artesunate + Amodiaquine) P-Alaxin® (Dihydroartemisinin + Piperaquine). Some are in Tablets, Injection, Suppositories, and Syrups, all from Bliss GVS Labs India. Also marketed by the company are the ever popular and anti-inflammatory drugs, Felvin® a brand of Piroxicam and Day by Day® range of Consumer healthcare products from Rajat Pharmachem PVT India. Then Grendopa® an anti-hypertensive, and Omefast® an anti-ulcer from Aquatic Formulation India among others.